Showing results (391-400 of 661) with videos related to
Sort By:
Pageof 67
Oral Oncology|December 23, 2019
Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinomaRoberto Carmagnani Pestana, Melody Becnel, Maria Laura Rubin, et al.Cancer|October 25, 2011
Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcomeLuisa M Solis, Carmen Behrens, M Gabriela Raso, et al.Cancer Prevention Research (Philadelphia, Pa.)|September 2, 2011
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancerAnita L Sabichi, J Jack Lee, H Barton Grossman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutationMaria G Raso, Carmen Behrens, Matthew H Herynk, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.Clinical Lung Cancer|November 5, 2003
Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancerFaye M Johnson, Jonathan M Kurie, Beverly O Peeples, et al.The Annals of Thoracic Surgery|October 8, 2003
The risk of second primary tumors after resection of stage I nonsmall cell lung cancerDavid Rice, Hyung-Woo Kim, Anita Sabichi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancyVassiliki A Papadimitrakopoulou, J Jack Lee, William N William, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 9, 2016
Transforming Cancer Prevention through Precision Medicine and Immune-oncologyThomas W Kensler, Avrum Spira, Judy E Garber, et al.American Journal of Cancer Research|December 23, 2015
Expression pattern of FGFR2, Grb2 and Plcγ1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinomaZahra Timsah, Jonathan Berrout, Milind Suraokar, et al.Pageof 67